The Beneficial Effect of the COVID-19 Vaccine Booster Dose among Healthcare Workers in an Infectious Diseases Center

Introduction: Healthcare workers in Poland received a booster dose of the BNT162b2 mRNA vaccine (Pfizer-BioNTech, Manufacturer: Pfizer, Inc., and BioNTech; Moguncja, Germany) at the beginning of October 2021. Here, we report on the preliminary results of an ongoing clinical study into the antibody r...

Descripción completa

Detalles Bibliográficos
Autores principales: Skrzat-Klapaczyńska, Agata, Bieńkowski, Carlo, Kowalska, Justyna, Paciorek, Marcin, Puła, Joanna, Krogulec, Dominika, Stengiel, Jarosław, Pawełczyk, Agnieszka, Perlejewski, Karol, Osuch, Sylwia, Radkowski, Marek, Horban, Andrzej
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9029317/
https://www.ncbi.nlm.nih.gov/pubmed/35455301
http://dx.doi.org/10.3390/vaccines10040552

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9029317/
https://www.ncbi.nlm.nih.gov/pubmed/35455301
http://dx.doi.org/10.3390/vaccines10040552

Ejemplares similares